# A Study of TIL in Advanced Solid Tumors (CZ)

> **NCT07294872** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Shanghai Juncell Therapeutics** · enrollment: 30 (estimated)

## Conditions studied

- Solid Tumor, Adult

## Interventions

- **BIOLOGICAL:** GC101TIL

## Key facts

- **NCT ID:** NCT07294872
- **Lead sponsor:** Shanghai Juncell Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-08
- **Primary completion:** 2026-09-20
- **Final completion:** 2029-09-20
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-01-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07294872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07294872, "A Study of TIL in Advanced Solid Tumors (CZ)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07294872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*